StockData
Pharvaris N.V. logo

Pharvaris N.V. (PHVS) income statement

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30
$31.55−0.73 (-2.26%)

Close on Nov 18, 2026Market cap $2.06BP/E –Yield –

See a number that looks wrong?